A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
NCT06717932
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Beta-Thalassemia
Sponsor
CorrectSequence Therapeutics Co., Ltd